Literature DB >> 8210985

Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch.

G Svaninger1, S Nordgren, T Oresland, L Hultén.   

Abstract

The incidence, the median time to first appearance, and the clinical pattern of pouchitis were prospectively studied in 180 patients operated on for ulcerative proctocolitis with a continent ileostomy (CI; 84 patients) and a pelvic pouch (PP; 96 patients). Median follow-up for CI patients was 8.5 years (range, 2-15 years) and for PP patients, 5 years (range, 1-8 years). Pouchitis, with symptoms severe enough to require treatment, developed in 33% (28 of 84) of CI and 47% (45 of 96) of PP patients. The cumulative risk of developing one or more episodes of pouchitis over a 5-year follow-up was 34% in CI patients and 51% in PP patients. The median time to first appearance of pouchitis was 5 and 12 months, respectively. Eighty-six per cent of CI patients with pouchitis (24 of 28) and 71% of PP patients (32 of 45) experienced their initial episode within the first 2 years. Sixty-four per cent (18 of 28) of the CI patients and 76% (34 of 45) of PP patients had one single or a few short-lasting episodes of pouchitis with various symptom-free intervals, whereas 18% of patients in each group (5 of 28 CI patients, 8 of 45 PP patients) had frequent relapses. Most of these patients responded promptly to metronidazole treatment. Eighteen per cent (5 of 28) of CI patients and 6% (3 of 45) of PP patients had long-lasting episodes with a poor response to treatment. In this long-term study the pouch inflammation proved eventually to be Crohn's disease in four patients (2.2%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8210985     DOI: 10.3109/00365529309098275

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  18 in total

1.  Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis.

Authors:  T Kühbacher; P Gionchetti; J Hampe; U Helwig; P Rosenstiel; M Campieri; H J Buhr; S Schreiber
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

2.  Pouch-Related Symptoms and Quality of Life in Patients with Ileal Pouch-Anal Anastomosis.

Authors:  Edward L Barnes; Hans H Herfarth; Robert S Sandler; Wenli Chen; Elizabeth Jaeger; Van M Nguyen; Amber R Robb; Michael D Kappelman; Christopher F Martin; Millie D Long
Journal:  Inflamm Bowel Dis       Date:  2017-07       Impact factor: 5.325

3.  Perinuclear anti-neutrophil cytoplasmic antibody and refractory pouchitis. A case-control study.

Authors:  J Aisenberg; J Wagreich; J Shim; S Almer; E Peen; T Heimann; I M Gelernt; A Greenstein; P Rubin; N Harpaz
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

Review 4.  Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis.

Authors:  Imerio Angriman; Marco Scarpa; Ignazio Castagliuolo
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  Reduced neurons in the ileum of proctocolectomized rat models.

Authors:  Chun-Mei Zhao; Helge E Myrvold; Duan Chen
Journal:  Med Mol Morphol       Date:  2014-11-29       Impact factor: 2.309

6.  High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis.

Authors:  P R Fleshner; E A Vasiliauskas; L Y Kam; N E Fleshner; J Gaiennie; M T Abreu-Martin; S R Targan
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

Review 7.  Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.

Authors:  Hoonmo L Koo; Herbert L DuPont
Journal:  Curr Opin Gastroenterol       Date:  2010-01       Impact factor: 3.287

8.  Does mesorectal preservation protect the ileoanal anastomosis after restorative proctocolectomy?

Authors:  Andreas D Rink; Irina Radinski; Karl-Heinz Vestweber
Journal:  J Gastrointest Surg       Date:  2008-09-03       Impact factor: 3.452

Review 9.  [Ileo pouch-anal anastomosis].

Authors:  A Stallmach; C Schmidt
Journal:  Internist (Berl)       Date:  2007-06       Impact factor: 0.743

10.  Partially hydrolyzed guar gum attenuates the severity of pouchitis in a rat model of ileal J pouch-anal anastomosis.

Authors:  Koray Atila; Cem Terzi; Aras Emre Canda; Serpil Tanriverdi Akhisaroglu; Hatice Sanli Avci; Sulen Sarioglu; Gulgun Oktay; Zeynep Gulay
Journal:  Dig Dis Sci       Date:  2008-07-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.